Mind + Muscle

technical minds + legal muscle


dig deep

5 Takeaways After Fed. Circ. Amgen – Sandoz Ruling

  • 07.21.15
  • Timothy J. Shea, Jr.
  • Law360

Timothy J. Shea, Jr. discusses with Law360 the implications of the U.S. Federal Circuit's ruling in Amgen Inc. v. Sandoz Inc., the Court's first interpretation of key provisions of the Biologics Price Competition and Innovation Act (BPCIA).

Discussing the rulings impact on the 180-day notice period and the patent dance mandate, Shea told Law360, "It does seem that the court is at least leaving open the question of whether it is mandatory if [the] patent dance is initiated." Shea noted that while the Amgen ruling that the patent dance is optional is a victory for biosimilar makers, its significance will fade as biosimilar applications are increasingly filed long before brand-name exclusivity lapses. "In that [scenario], it might be more advantageous for the biosimilar maker to use the patent dance to vet all patent issues, knowing that there's no urgency to get to market," Shea told Law360.

Discussing a footnote in the opinion suggesting that infringement suits brought under the BPCIA could be premised on process patents, Shea remarked, "The court here concludes that [the patent infringement statute] eliminates that concern and specifically allows the [branded manufacturer] to assert such process patents."

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.